Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Prolonged Response and Restoration of Functional Independence with Bevacizumab plus Vinorelbine as Third-Line Treatment for Breast Cancer-Related Leptomeningeal Metastases.

Case reports in oncology

Le Rhun E, Taillibert S, Boulanger T, Zairi F, Bonneterre J, Chamberlain MC.
PMID: 25848355
Case Rep Oncol. 2015 Feb 12;8(1):72-7. doi: 10.1159/000375293. eCollection 2015.

BACKGROUND: Survival of patients with leptomeningeal metastases (LM) and impaired functional status is limited to several months, and rarely does neurological function improve with treatment.CASE REPORT: A 34-year-old female with hormone-negative and HER2-positive metastatic breast cancer was diagnosed with...

Cite
Le Rhun E, Taillibert S, Boulanger T, et al. Prolonged Response and Restoration of Functional Independence with Bevacizumab plus Vinorelbine as Third-Line Treatment for Breast Cancer-Related Leptomeningeal Metastases. Case Rep Oncol. 2015;8(1):72-7doi: 10.1159/000375293.
Le Rhun, E., Taillibert, S., Boulanger, T., Zairi, F., Bonneterre, J., & Chamberlain, M. C. (2015). Prolonged Response and Restoration of Functional Independence with Bevacizumab plus Vinorelbine as Third-Line Treatment for Breast Cancer-Related Leptomeningeal Metastases. Case reports in oncology, 8(1), 72-7. https://doi.org/10.1159/000375293
Le Rhun, Emilie, et al. "Prolonged Response and Restoration of Functional Independence with Bevacizumab plus Vinorelbine as Third-Line Treatment for Breast Cancer-Related Leptomeningeal Metastases." Case reports in oncology vol. 8,1 (2015): 72-7. doi: https://doi.org/10.1159/000375293
Le Rhun E, Taillibert S, Boulanger T, Zairi F, Bonneterre J, Chamberlain MC. Prolonged Response and Restoration of Functional Independence with Bevacizumab plus Vinorelbine as Third-Line Treatment for Breast Cancer-Related Leptomeningeal Metastases. Case Rep Oncol. 2015 Feb 12;8(1):72-7. doi: 10.1159/000375293. eCollection 2015. PMID: 25848355; PMCID: PMC4361905.
Copy Download .nbib Format: NLM
The future of high-grade glioma: Where we are and where are we going.

Surgical neurology international

Le Rhun E, Rhun EL, Taillibert S, Chamberlain MC.
PMID: 25722939
Surg Neurol Int. 2015 Feb 13;6:S9-S44. doi: 10.4103/2152-7806.151331. eCollection 2015.

High-grade glioma (HGG) are optimally treated with maximum safe surgery, followed by radiotherapy (RT) and/or systemic chemotherapy (CT). Recently, the treatment of newly diagnosed anaplastic glioma (AG) has changed, particularly in patients with 1p19q codeleted tumors. Results of trials...

Cite
Le Rhun E, Rhun EL, Taillibert S, et al. The future of high-grade glioma: Where we are and where are we going. Surg Neurol Int. 2015;6:S9-S44doi: 10.4103/2152-7806.151331.
Le Rhun, E., Rhun, E. L., Taillibert, S., & Chamberlain, M. C. (2015). The future of high-grade glioma: Where we are and where are we going. Surgical neurology international, 6S9-S44. https://doi.org/10.4103/2152-7806.151331
Le Rhun, Emilie, et al. "The future of high-grade glioma: Where we are and where are we going." Surgical neurology international vol. 6 (2015): S9-S44. doi: https://doi.org/10.4103/2152-7806.151331
Le Rhun E, Rhun EL, Taillibert S, Chamberlain MC. The future of high-grade glioma: Where we are and where are we going. Surg Neurol Int. 2015 Feb 13;6:S9-S44. doi: 10.4103/2152-7806.151331. eCollection 2015. PMID: 25722939; PMCID: PMC4338495.
Copy Download .nbib Format: NLM
The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns.

International journal of radiation oncology, biology, physics

Glas M, Ballo MT, Bomzon Z, Urman N, Levi S, Lavy-Shahaf G, Jeyapalan S, Sio TT, DeRose PM, Misch M, Taillibert S, Ram Z, Hottinger AF, Easaw J, Kim CY, Mohan S, Stupp R.
PMID: 34963556
Int J Radiat Oncol Biol Phys. 2021 Dec 26; doi: 10.1016/j.ijrobp.2021.12.152. Epub 2021 Dec 26.

BACKGROUND: Tumor-treating fields (TTFields) is an antimitotic treatment modality that interferes with glioblastoma cell division and organelle assembly by delivering low-intensity alternating electric fields to the tumor. A previous analysis from the pivotal EF-14 trial demonstrated a clear correlation...

Cite
Glas M, Ballo MT, Bomzon Z, et al. The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns. Int J Radiat Oncol Biol Phys. 2021;doi: 10.1016/j.ijrobp.2021.12.152.
Glas, M., Ballo, M. T., Bomzon, Z., Urman, N., Levi, S., Lavy-Shahaf, G., Jeyapalan, S., Sio, T. T., DeRose, P. M., Misch, M., Taillibert, S., Ram, Z., Hottinger, A. F., Easaw, J., Kim, C. Y., Mohan, S., & Stupp, R. (2021). The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns. International journal of radiation oncology, biology, physics, . https://doi.org/10.1016/j.ijrobp.2021.12.152
Glas, Martin, et al. "The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns." International journal of radiation oncology, biology, physics vol. (2021). doi: https://doi.org/10.1016/j.ijrobp.2021.12.152
Glas M, Ballo MT, Bomzon Z, Urman N, Levi S, Lavy-Shahaf G, Jeyapalan S, Sio TT, DeRose PM, Misch M, Taillibert S, Ram Z, Hottinger AF, Easaw J, Kim CY, Mohan S, Stupp R. The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns. Int J Radiat Oncol Biol Phys. 2021 Dec 26; doi: 10.1016/j.ijrobp.2021.12.152. Epub 2021 Dec 26. PMID: 34963556.
Copy Download .nbib Format: NLM
Carcinomatous meningitis: Leptomeningeal metastases in solid tumors.

Surgical neurology international

Le Rhun E, Taillibert S, Chamberlain MC.
PMID: 23717798
Surg Neurol Int. 2013 May 02;4:S265-88. doi: 10.4103/2152-7806.111304. Print 2013.

Leptomeningeal metastasis (LM) results from metastatic spread of cancer to the leptomeninges, giving rise to central nervous system dysfunction. Breast cancer, lung cancer, and melanoma are the most frequent causes of LM among solid tumors in adults. An early...

Cite
Le Rhun E, Taillibert S, Chamberlain MC. Carcinomatous meningitis: Leptomeningeal metastases in solid tumors. Surg Neurol Int. 2013;4:S265-88doi: 10.4103/2152-7806.111304.
Le Rhun, E., Taillibert, S., & Chamberlain, M. C. (2013). Carcinomatous meningitis: Leptomeningeal metastases in solid tumors. Surgical neurology international, 4S265-88. https://doi.org/10.4103/2152-7806.111304
Le Rhun, Emilie, et al. "Carcinomatous meningitis: Leptomeningeal metastases in solid tumors." Surgical neurology international vol. 4 (2013): S265-88. doi: https://doi.org/10.4103/2152-7806.111304
Le Rhun E, Taillibert S, Chamberlain MC. Carcinomatous meningitis: Leptomeningeal metastases in solid tumors. Surg Neurol Int. 2013 May 02;4:S265-88. doi: 10.4103/2152-7806.111304. Print 2013. PMID: 23717798; PMCID: PMC3656567.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries